Ivo Valter - Publications

LUMIADE 3: Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis.

Journal: Journal of the Endocrine Society

Published: June 11, 2025

Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 16, 2020

Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: November 15, 2019

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: July 20, 2018

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 08, 2017

Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis.

Journal: BMC musculoskeletal disorders

Published: August 23, 2017

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: August 10, 2017

Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial.

Journal: Mayo Clinic proceedings

Published: July 22, 2016

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.

Journal: Bone

Published: April 12, 2016

Effects of up to 5 years of denosumab treatment on bone histology and histomorphometry: the FREEDOM study extension.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: February 11, 2014

Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.

Journal: Bone

Published: April 19, 2012